Toprak O - Search Results

1

Discontinuing Hemodialysis with Patient Care and a Successful 9-Year Follow-up in a Patient Presumed to have End-Stage Kidney Disease Scheduled to Lifelong Hemodialysis: A Case Report.

Toprak O, Bozyel EA, Alp B. Toprak O, et al. Clin Pract. 2021 Feb 26;11(1):131-142. doi: 10.3390/clinpract11010019. Clin Pract. 2021. PMID: 33652801 Free PMC article.

2

Discontinuation of Hemodialysis After 8 Years in Favor of Toprak's Kidney Care in a Patient with End-Stage Kidney Disease.

Toprak O, Bozyel EA, Alp B, Kirik A. Toprak O, et al. Am J Case Rep. 2021 Apr 25;22:e930857. doi: 10.12659/AJCR.930857. Am J Case Rep. 2021. PMID: 33895768 Free PMC article.

3

Dialysis-requiring acute kidney injury and electrolyte imbalances as a result of prodromal herpes zoster in a kidney transplant recipient.

Toprak O, Turan OF, Bozyel EA, Alp B, Ucdu GZ. Toprak O, et al. Transpl Infect Dis. 2021 Aug;23(4):e13578. doi: 10.1111/tid.13578. Epub 2021 Feb 6. Transpl Infect Dis. 2021. PMID: 33522083 No abstract available.

4

The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study.

Toprak O, Sarı Y, Koç A, Sarı E, Kırık A. Toprak O, et al. Clin Interv Aging. 2017 Feb 24;12:437-444. doi: 10.2147/CIA.S129377. eCollection 2017. Clin Interv Aging. 2017. PMID: 28280316 Free PMC article.

5

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study.

Toprak O, Kurt H, Sarı Y, Şarkış C, Us H, Kırık A. Toprak O, et al. Kidney Blood Press Res. 2017;42(1):33-42. doi: 10.1159/000468530. Epub 2017 Mar 13. Kidney Blood Press Res. 2017. PMID: 28297698 Free article. Clinical Trial.

6

Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.

Cirit M, Toprak O, Yesil M, Bayata S, Postaci N, Pupim L, Esi E. Cirit M, et al. Among authors: toprak o. Nephron Clin Pract. 2006;104(1):c20-7. doi: 10.1159/000093255. Epub 2006 May 9. Nephron Clin Pract. 2006. PMID: 16685140

7

The possible efficacy of artichoke in fluconazole related hepatotoxicity.

Kurt H, Toprak O, Bülbül E. Kurt H, et al. Among authors: toprak o. Case Reports Hepatol. 2014;2014:697359. doi: 10.1155/2014/697359. Epub 2014 Sep 3. Case Reports Hepatol. 2014. PMID: 25374729 Free PMC article.

8

Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment.

Toprak O, Cirit M, Yesil M, Byrne DW, Postaci N, Bayata S, Majchrzak KM, Esi E. Toprak O, et al. Kidney Blood Press Res. 2006;29(1):2-9. doi: 10.1159/000092481. Epub 2006 Mar 22. Kidney Blood Press Res. 2006. PMID: 16582571

9

Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.

Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Toprak O, et al. Catheter Cardiovasc Interv. 2006 Feb;67(2):227-35. doi: 10.1002/ccd.20598. Catheter Cardiovasc Interv. 2006. PMID: 16400673

10

Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.

Toprak O, Cirit M, Yesil M, Bayata S, Tanrisev M, Varol U, Ersoy R, Esi E. Toprak O, et al. Nephrol Dial Transplant. 2007 Mar;22(3):819-26. doi: 10.1093/ndt/gfl636. Epub 2006 Nov 7. Nephrol Dial Transplant. 2007. PMID: 17090607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters